Annual CFI
$49.68 M
-$24.39 M-32.93%
31 December 2023
Summary:
Exact Sciences annual cash flow from investing activities is currently $49.68 million, with the most recent change of -$24.39 million (-32.93%) on 31 December 2023. During the last 3 years, it has risen by +$1.13 billion (+104.59%). EXAS annual CFI is now -32.93% below its all-time high of $74.07 million, reached on 31 December 2022.EXAS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$81.72 M
+$65.41 M+44.46%
30 September 2024
Summary:
Exact Sciences quarterly cash flow from investing activities is currently -$81.72 million, with the most recent change of +$65.41 million (+44.46%) on 30 September 2024. Over the past year, it has dropped by -$14.95 million (-22.39%). EXAS quarterly CFI is now -109.53% below its all-time high of $857.44 million, reached on 30 September 2019.EXAS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$467.05 M
-$48.75 M-11.65%
30 September 2024
Summary:
Exact Sciences TTM cash flow from investing activities is currently -$467.05 million, with the most recent change of -$48.75 million (-11.65%) on 30 September 2024. Over the past year, it has dropped by -$516.73 million (-1040.14%). EXAS TTM CFI is now -166.35% below its all-time high of $703.90 million, reached on 30 September 2019.EXAS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXAS Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -22.4% | -1040.1% |
3 y3 years | +104.6% | -204.2% | +56.8% |
5 y5 years | +139.9% | +90.3% | -275.4% |
EXAS Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -32.9% | +104.6% | -198.5% | +52.3% | -321.7% | +56.8% |
5 y | 5 years | -32.9% | +104.6% | -198.5% | +90.3% | -321.7% | +68.2% |
alltime | all time | -32.9% | +104.6% | -109.5% | +90.3% | -166.3% | +68.2% |
Exact Sciences Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$81.72 M(-44.5%) | -$467.05 M(+11.7%) |
June 2024 | - | -$147.13 M(-14.2%) | -$418.30 M(+104.3%) |
Mar 2024 | - | -$171.44 M(+156.8%) | -$204.70 M(-512.0%) |
Dec 2023 | $49.68 M(-32.9%) | -$66.77 M(+102.5%) | $49.68 M(-14.8%) |
Sept 2023 | - | -$32.97 M(-149.6%) | $58.29 M(-62.7%) |
June 2023 | - | $66.47 M(-19.9%) | $156.26 M(+40.2%) |
Mar 2023 | - | $82.94 M(-242.6%) | $111.45 M(+50.5%) |
Dec 2022 | $74.07 M(-106.8%) | -$58.16 M(-189.5%) | $74.07 M(-64.8%) |
Sept 2022 | - | $65.00 M(+200.1%) | $210.66 M(+118.5%) |
June 2022 | - | $21.66 M(-52.5%) | $96.41 M(-113.4%) |
Mar 2022 | - | $45.56 M(-41.9%) | -$719.01 M(-33.6%) |
Dec 2021 | -$1.08 B(+54.1%) | $78.44 M(-259.3%) | -$1.08 B(-26.2%) |
Sept 2021 | - | -$49.24 M(-93.8%) | -$1.47 B(+4.7%) |
June 2021 | - | -$793.77 M(+150.0%) | -$1.40 B(+128.3%) |
Mar 2021 | - | -$317.51 M(+3.5%) | -$613.70 M(-12.6%) |
Dec 2020 | -$702.04 M(+464.2%) | -$306.64 M(-1922.2%) | -$702.04 M(-43.1%) |
Sept 2020 | - | $16.83 M(-363.8%) | -$1.23 B(+213.9%) |
June 2020 | - | -$6.38 M(-98.4%) | -$392.91 M(-19.7%) |
Mar 2020 | - | -$405.85 M(-51.6%) | -$489.07 M(+293.1%) |
Dec 2019 | -$124.43 M(-84.1%) | -$838.13 M(-197.7%) | -$124.43 M(-117.7%) |
Sept 2019 | - | $857.44 M(-936.2%) | $703.90 M(-402.7%) |
June 2019 | - | -$102.54 M(+148.9%) | -$232.53 M(-10.8%) |
Mar 2019 | - | -$41.20 M(+320.3%) | -$260.77 M(-66.7%) |
Dec 2018 | -$782.30 M(+386.5%) | -$9.80 M(-87.6%) | -$782.30 M(+4.6%) |
Sept 2018 | - | -$78.99 M(-39.6%) | -$747.84 M(-6.0%) |
June 2018 | - | -$130.78 M(-76.8%) | -$795.45 M(+6.4%) |
Mar 2018 | - | -$562.73 M(-2382.5%) | -$747.46 M(+364.8%) |
Dec 2017 | -$160.81 M(+1296.0%) | $24.65 M(-119.5%) | -$160.81 M(-8.7%) |
Sept 2017 | - | -$126.60 M(+52.9%) | -$176.17 M(+13.8%) |
June 2017 | - | -$82.79 M(-446.0%) | -$154.85 M(+279.9%) |
Mar 2017 | - | $23.93 M(+157.6%) | -$40.76 M(+253.9%) |
Dec 2016 | -$11.52 M(-82.2%) | $9.29 M(-108.8%) | -$11.52 M(-169.3%) |
Sept 2016 | - | -$105.28 M(-436.4%) | $16.63 M(-194.9%) |
June 2016 | - | $31.30 M(-41.1%) | -$17.52 M(-40.0%) |
Mar 2016 | - | $53.17 M(+42.0%) | -$29.18 M(-54.9%) |
Dec 2015 | -$64.75 M(-44.8%) | $37.44 M(-126.8%) | -$64.75 M(-55.7%) |
Sept 2015 | - | -$139.42 M(-810.1%) | -$146.29 M(-789.2%) |
June 2015 | - | $19.63 M(+11.6%) | $21.23 M(-118.1%) |
Mar 2015 | - | $17.60 M(-139.9%) | -$116.99 M(-0.3%) |
Dec 2014 | -$117.29 M(+235.4%) | -$44.10 M(-257.0%) | -$117.29 M(+95.6%) |
Sept 2014 | - | $28.09 M(-123.7%) | -$59.97 M(-35.3%) |
June 2014 | - | -$118.59 M(-785.3%) | -$92.76 M(+278.8%) |
Mar 2014 | - | $17.30 M(+30.9%) | -$24.49 M(-30.0%) |
Dec 2013 | -$34.97 M(-8.7%) | $13.22 M(-381.6%) | -$34.97 M(-6.3%) |
Sept 2013 | - | -$4.69 M(-90.7%) | -$37.33 M(-49.3%) |
June 2013 | - | -$50.32 M(-837.3%) | -$73.67 M(+319.4%) |
Mar 2013 | - | $6.82 M(-37.1%) | -$17.57 M(-54.2%) |
Dec 2012 | -$38.32 M | $10.85 M(-126.5%) | -$38.32 M(+3.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2012 | - | -$41.03 M(-809.0%) | -$36.91 M(+65.6%) |
June 2012 | - | $5.79 M(-141.5%) | -$22.28 M(-60.3%) |
Mar 2012 | - | -$13.93 M(-213.5%) | -$56.09 M(+29.2%) |
Dec 2011 | -$43.41 M(+190.9%) | $12.27 M(-146.4%) | -$43.41 M(-25.7%) |
Sept 2011 | - | -$26.41 M(-5.8%) | -$58.45 M(+76.5%) |
June 2011 | - | -$28.02 M(+2160.0%) | -$33.11 M(+133.7%) |
Mar 2011 | - | -$1.24 M(-55.3%) | -$14.16 M(-5.1%) |
Dec 2010 | -$14.92 M(+420.4%) | -$2.78 M(+159.4%) | -$14.92 M(+38.6%) |
Sept 2010 | - | -$1.07 M(-88.2%) | -$10.76 M(-773.1%) |
June 2010 | - | -$9.08 M(+355.1%) | $1.60 M(-86.8%) |
Mar 2010 | - | -$2.00 M(-244.5%) | $12.09 M(-521.8%) |
Dec 2009 | -$2.87 M(-134.8%) | $1.38 M(-87.8%) | -$2.87 M(-27.8%) |
Sept 2009 | - | $11.29 M(+697.5%) | -$3.97 M(-69.5%) |
June 2009 | - | $1.42 M(-108.4%) | -$13.04 M(+15.8%) |
Mar 2009 | - | -$16.96 M(-6265.8%) | -$11.27 M(-236.6%) |
Dec 2008 | $8.25 M(+2.6%) | $275.00 K(-87.6%) | $8.25 M(+11.4%) |
Sept 2008 | - | $2.22 M(-30.4%) | $7.40 M(-30.7%) |
June 2008 | - | $3.19 M(+24.7%) | $10.68 M(+17.6%) |
Mar 2008 | - | $2.56 M(-549.1%) | $9.08 M(+13.0%) |
Dec 2007 | $8.04 M(+77.6%) | -$570.00 K(-110.4%) | $8.04 M(-6.7%) |
Sept 2007 | - | $5.50 M(+245.6%) | $8.61 M(-9263.8%) |
June 2007 | - | $1.59 M(+4.9%) | -$94.00 K(-102.1%) |
Mar 2007 | - | $1.52 M(>+9900.0%) | $4.42 M(-2.3%) |
Dec 2006 | $4.53 M(-71.3%) | $8000.00(-100.2%) | $4.53 M(+31.0%) |
Sept 2006 | - | -$3.21 M(-152.6%) | $3.46 M(-63.4%) |
June 2006 | - | $6.10 M(+276.3%) | $9.44 M(-38.1%) |
Mar 2006 | - | $1.62 M(-252.7%) | $15.25 M(-3.2%) |
Dec 2005 | $15.76 M(-165.3%) | -$1.06 M(-138.3%) | $15.76 M(-13.4%) |
Sept 2005 | - | $2.77 M(-76.7%) | $18.19 M(-21.1%) |
June 2005 | - | $11.92 M(+459.6%) | $23.05 M(+303.4%) |
Mar 2005 | - | $2.13 M(+55.2%) | $5.71 M(-123.7%) |
Dec 2004 | -$24.14 M(-354.8%) | $1.37 M(-82.0%) | -$24.14 M(+17.9%) |
Sept 2004 | - | $7.63 M(-240.8%) | -$20.48 M(-43.2%) |
June 2004 | - | -$5.42 M(-80.5%) | -$36.08 M(+73.3%) |
Mar 2004 | - | -$27.72 M(-650.6%) | -$20.82 M(-319.8%) |
Dec 2003 | $9.47 M(-133.7%) | $5.04 M(-163.2%) | $9.47 M(+119.3%) |
Sept 2003 | - | -$7.97 M(-181.0%) | $4.32 M(-129.4%) |
June 2003 | - | $9.84 M(+283.1%) | -$14.70 M(-41.6%) |
Mar 2003 | - | $2.57 M(-2281.8%) | -$25.16 M(-10.5%) |
Dec 2002 | -$28.10 M(+515.5%) | -$117.70 K(-99.6%) | -$28.10 M(-6.5%) |
Sept 2002 | - | -$26.98 M(+4180.5%) | -$30.05 M(+736.7%) |
June 2002 | - | -$630.40 K(+70.7%) | -$3.59 M(+1.2%) |
Mar 2002 | - | -$369.40 K(-82.2%) | -$3.55 M(-22.3%) |
Dec 2001 | -$4.57 M(+322.4%) | -$2.07 M(+296.3%) | -$4.57 M(+82.9%) |
Sept 2001 | - | -$522.30 K(-10.9%) | -$2.50 M(+26.5%) |
June 2001 | - | -$586.30 K(-57.8%) | -$1.97 M(+42.2%) |
Mar 2001 | - | -$1.39 M | -$1.39 M |
Dec 2000 | -$1.08 M(+49.8%) | - | - |
Dec 1999 | -$721.60 K | - | - |
FAQ
- What is Exact Sciences annual cash flow from investing activities?
- What is the all time high annual CFI for Exact Sciences?
- What is Exact Sciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Exact Sciences?
- What is Exact Sciences quarterly CFI year-on-year change?
- What is Exact Sciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Exact Sciences?
- What is Exact Sciences TTM CFI year-on-year change?
What is Exact Sciences annual cash flow from investing activities?
The current annual CFI of EXAS is $49.68 M
What is the all time high annual CFI for Exact Sciences?
Exact Sciences all-time high annual cash flow from investing activities is $74.07 M
What is Exact Sciences quarterly cash flow from investing activities?
The current quarterly CFI of EXAS is -$81.72 M
What is the all time high quarterly CFI for Exact Sciences?
Exact Sciences all-time high quarterly cash flow from investing activities is $857.44 M
What is Exact Sciences quarterly CFI year-on-year change?
Over the past year, EXAS quarterly cash flow from investing activities has changed by -$14.95 M (-22.39%)
What is Exact Sciences TTM cash flow from investing activities?
The current TTM CFI of EXAS is -$467.05 M
What is the all time high TTM CFI for Exact Sciences?
Exact Sciences all-time high TTM cash flow from investing activities is $703.90 M
What is Exact Sciences TTM CFI year-on-year change?
Over the past year, EXAS TTM cash flow from investing activities has changed by -$516.73 M (-1040.14%)